| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine (Y.S.H., H.Z., V.K., T.J.M., K.W.N.) The
University of Melbourne St. Vincents Hospital Fitzroy,
Victoria, 3065 Australia
The Garvan Institute of Medical
Research (J.A.E.), St. Vincents Hospital Darlinghurst, New
South Wales 2010, Australia
The rat homeobox gene, rHox, was cloned from a rat
osteosarcoma cDNA library. Southwestern and gel mobility shift analyses
showed that rHox binds to the promoter regions of collagen (
1)I and
osteocalcin genes while transient transfection with rHox resulted in
repression of their respective promoter activities. In situ
hybridization studies showed that rHox mRNA was widely expressed in
osteoblasts, chondrocytes, skeletal muscle, skin epidermis, and
bronchial and intestinal epithelial cells, as well as cardiac muscle in
embryonic and newborn mice. However in 3-month-old mice, rHox mRNA
expression was restricted to osteoblasts, megakaryocytes, and
myocardium. Bone morphogenetic protein 2, a growth factor that
commits mesenchymal progenitor cells to differentiate into osteoblasts,
down-regulated rHox mRNA expression by 4050% in UMR 201, a rat
preosteoblast cell line, in a time- and dose-dependent manner. In
contrast, PTH-related protein (PTHrP), recently shown to be a
negative regulator of chondrocyte differentiation, significantly
enhanced rHox mRNA expression in UMR 10606 osteoblastic cells by
3-fold at 24 h while at the same time down-regulating expression
of pro-
1(I) collagen mRNA by 60%. Expression of rHox mRNA in
calvarial osteoblasts derived from PTHrP -/- mice was approximately
15% of that observed in similar cells obtained from normal mice. In
conclusion, current evidence suggests that rHox acts as a negative
regulator of osteoblast differentiation. Furthermore, down-regulation
of rHox mRNA by bone morphogenetic protein 2 and its up-regulation by
PTHrP support a role of the homeodomain protein, rHox, in osteoblast
differentiation.
This article has been cited by other articles:
![]() |
H. Zhou, V. Kartsogiannis, Y. S. Hu, J. Elliott, J. M. W. Quinn, W. J. McKinstry, M. T. Gillespie, and K. W. Ng A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation J. Biol. Chem., April 27, 2001; 276(18): 14916 - 14923. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yin, G. M. Edelman, and P. W. Vanderklish The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes PNAS, February 19, 2002; 99(4): 2368 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Jones, R. Meech, D. B. Edelman, R. J. Oakey, and P. L. Jones Prx1 Controls Vascular Smooth Muscle Cell Proliferation and Tenascin-C Expression and Is Upregulated With Prx2 in Pulmonary Vascular Disease Circ. Res., July 20, 2001; 89(2): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |